Smart Nanocarriers Based on Cyclodextrin Derivatives for Controlled Anticancer Drug Release
DOI:
https://doi.org/10.70749/ijbr.v3i8.2127Keywords:
Cyclodextrin nanogel; Doxorubicin; Redox-responsive release; pH-triggered delivery; Hyaluronic acid targeting; Pharmacokinetics; Antitumor efficacy; Cardiotoxicity reduction.Abstract
We engineered redox-responsive cyclodextrin (CD) nanogels for doxorubicin (DOX) and benchmarked them against β-CD inclusion complexes. Nanogels were formed by EDC/NHS coupling of carboxymethyl-β-CD with cystamine, optionally PEGylated and HA-targeted via adamantane–β-CD host–guest; DOX was loaded overnight and formulations characterized (DLS/TEM) and tested by dialysis release (pH 7.4/5.5 ± 10 mM GSH), MTT uptake/viability (MCF-7, MDA-MB-231, HeLa, MCF-7/ADR), MCF-7 xenografts (5 mg/kg i.v., q4d×4), and satellite PK; stats used one-way ANOVA with Tukey (p<0.05). CD-SS nanogels achieved DL 8.2±0.9% and EE 78±6% with 112±14 nm size; solubility rose 165× versus free DOX (β-CD complexes 60–80×) and stability improved (48 h remaining 88±3% vs 52±5% free; t½ 72±6 h vs 29±3 h, p<0.01). Release was minimal at pH 7.4 (38.2±2.7%/48 h) but strongly triggered at pH 5.5+10 mM GSH (97.8±1.4%/48 h; t50 6.2 h). In vivo, tumor volumes fell to 380±90 mm³ (PEG-nanogel; TGI 76%) and 260±75 mm³ (HA-nanogel; TGI 83%) vs 820±140 mm³ (free DOX); ANOVA p<0.001, Tukey p<0.05, with higher intratumoral DOX (7.9–10.4 vs 2.8–3.5 µg/g) and improved safety (CK-MB 182–198 vs 318 U/L; troponin I 0.024–0.028 vs 0.067 ng/mL; 100% survival). Overall, CD-SS nanogels provide pH/redox-responsive release, better PK, greater efficacy, and reduced cardiotoxicity at equal dose.
Downloads
References
1. P?duraru, L., et al., Smart Drug Delivery Systems Based on Cyclodextrins and Chitosan for Cancer Therapy. Pharmaceuticals, 2025. 18(4): p. 564.
https://doi.org/10.3390/ph18040564
2. Marabada, D., et al., Cyclodextrin based nanoparticles for smart drug delivery in colorectal cancer. Chemical Biology & Drug Design, 2023. 102(6): p. 1618-1631.
https://doi.org/10.1111/cbdd.14344
3. Bognanni, N., et al., Cyclodextrin polymers as delivery systems for targeted anti-cancer chemotherapy. Molecules, 2021. 26(19): p. 6046.
https://doi.org/10.3390/molecules26196046
4. Real, D.A., et al., Cyclodextrin-modified nanomaterials for drug delivery: Classification and advances in controlled release and bioavailability. Pharmaceutics, 2021. 13(12): p. 2131.
https://doi.org/10.3390/pharmaceutics13122131
5. Teng, J., et al., Synthesis of cyclodextrin?based temperature/enzyme?responsive nanoparticles and application in antitumor drug delivery. Journal of Molecular Structure, 2023. 1274: p. 134596.
https://doi.org/10.1016/j.molstruc.2022.134596
6. P?duraru, D.N., et al., An updated overview of cyclodextrin-based drug delivery systems for cancer therapy. Pharmaceutics, 2022. 14(8): p. 1748.
https://doi.org/10.3390/pharmaceutics14081748
7. Pilch, J., et al., pH-responsive drug delivery nanoplatforms as smart carriers of unsymmetrical bisacridines for targeted cancer therapy. Pharmaceutics, 2023. 15(1): p. 201.
https://doi.org/10.3390/pharmaceutics15010201
8. Santos, A.C., et al., Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies. Drug Delivery and Translational Research, 2021. 11(1): p. 49-71.
https://doi.org/10.1007/s13346-020-00778-5
9. Hosseini, M., et al., Drug delivery based on chitosan, ?-cyclodextrin and sodium carboxymethyl cellulose as well as nanocarriers for advanced leukemia treatment. Biomedicine & Pharmacotherapy, 2022. 153: p. 113369.
https://doi.org/10.1016/j.biopha.2022.113369
10. Sivakumar, P.M., et al., Cyclodextrin-based nanosystems as drug carriers for cancer therapy. Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents), 2020. 20(11): p. 1327-1339.
https://doi.org/10.2174/1871520619666190906160359
11. Akhondi, M., E. Jamalizadeh, and A. Mohebbi, MD and DFT calculations on the structural variations of amino-cyclodextrin as a pH-sensitive carrier for smart carriage and release of Doxorubicin. Journal of Molecular Structure, 2021. 1230: p. 129855.
https://doi.org/10.1016/j.molstruc.2020.129855
12. Ramasamy, S., et al., Magnetic hydroxyapatite nanomaterial-cyclodextrin tethered polymer hybrids as anticancer drug carriers. Materials advances, 2021. 2(10): p. 3315-3327.
https://doi.org/10.1039/d1ma00142f
13. Hoti, G., et al., Strategies to develop cyclodextrin-based nanosponges for smart drug delivery, in Smart Drug Delivery. 2021, Usama Ahmad. p. 2-22.
https://doi.org/10.5772/intechopen.100182
14. Bose, R., et al., Cyclodextrin nanoparticles in targeted cancer theranostics. Frontiers in Pharmacology, 2023. 14: p. 1218867.
https://doi.org/10.3389/fphar.2023.1218867
15. Nunes, A.M., et al., Intelligent Systems based on Cyclodextrins for the Treatment of Breast Cancer. Current Pharmaceutical Design, 2024. 30(30): p. 2345-2363.
https://doi.org/10.2174/0113ACmhmSBt4yFipJNKvNhngScYx4YpAX5
16. Kenchegowda, M., et al., Smart nanocarriers as an emerging platform for cancer therapy: A review. Molecules, 2021. 27(1): p. 146.
https://doi.org/10.3390/molecules27010146
17. Varan, G., et al., Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver. Journal of drug targeting, 2021. 29(4): p. 439-453.
https://doi.org/10.1080/1061186x.2020.1853743
18. Mayol, B., et al., A novel Janus nanomachine based on mesoporous silica nanoparticles anisotropically modified with PAMAM dendrimers for enzyme-controlled drug delivery. Nanoscale, 2025. 17(13): p. 8183-8191.
https://doi.org/10.1039/d4nr03740e
19. Puiu, R.A., et al., Anti-cancer nanopowders and MAPLE-fabricated thin films based on SPIONs surface modified with paclitaxel loaded ?-cyclodextrin. Pharmaceutics, 2021. 13(9): p. 1356.
https://doi.org/10.3390/pharmaceutics13091356
20. Celesti, C., et al., A smart ?-Cyclodextrin-Aza [5] Helicene system for enhanced gemcitabine delivery and tracking in cancer cells. International Journal of Pharmaceutics, 2025: p. 125611.
https://doi.org/10.1016/j.ijpharm.2025.125611
21. Mollazadeh, S., M. Mackiewicz, and M. Yazdimamaghani, Recent advances in the redox-responsive drug delivery nanoplatforms: A chemical structure and physical property perspective. Materials Science and Engineering: C, 2021. 118: p. 111536.
https://doi.org/10.1016/j.msec.2020.111536
22. Batool, N., et al., Orally administered, biodegradable and biocompatible hydroxypropyl-?-cyclodextrin grafted poly (methacrylic acid) hydrogel for pH sensitive sustained anticancer drug delivery. Gels, 2022. 8(3): p. 190.
https://doi.org/10.3390/gels8030190
23. Najm, A., et al., Chitosan and Cyclodextrins-Versatile Materials Used to Create Drug Delivery Systems for Gastrointestinal Cancers. Pharmaceutics, 2023. 16(1): p. 43.
https://doi.org/10.3390/pharmaceutics16010043
24. Dumontel, B., et al., Natural biopolymers as smart coating materials of mesoporous silica nanoparticles for drug delivery. Pharmaceutics, 2023. 15(2): p. 447.
https://doi.org/10.3390/pharmaceutics15020447
25. Wankar, J., et al., Recent advances in host-guest self?assembled cyclodextrin carriers: Implications for responsive drug delivery and biomedical engineering. Advanced Functional Materials, 2020. 30(44): p. 1909049.
https://doi.org/10.1002/adfm.201909049
26. Sanadgol, N. and J. Wackerlig, Developments of smart drug-delivery systems based on magnetic molecularly imprinted polymers for targeted cancer therapy: a short review. Pharmaceutics, 2020. 12(9): p. 831.
https://doi.org/10.3390/pharmaceutics12090831
27. Mihanfar, A., et al., Doxorubicin loaded magnetism nanoparticles based on cyclodextrin dendritic-graphene oxide inhibited MCF-7 cell proliferation. Biomolecular concepts, 2021. 12(1): p. 8-15.
https://doi.org/10.1515/bmc-2021-0002
28. Devika, V., et al., Stimuli-responsive cyclodextrin-based materials for biomedical applications. Materials Today: Proceedings, 2024.
https://doi.org/10.1016/j.matpr.2024.05.130
29. Hosseinzadeh, H., et al., Preparation of amino-functionalized ?-cyclodextrin/Fe3O4@ SiO2 magnetic nanocarrier for controlled release of doxorubicin, an anticancer drug. Arabian Journal for Science and Engineering, 2024. 49(1): p. 459-473.
https://doi.org/10.1007/s13369-023-08202-z
30. Virmani, T., et al., Amelioration of cancer employing chitosan, its derivatives, and chitosan-based nanoparticles: Recent updates. Polymers, 2023. 15(13): p. 2928.
https://doi.org/10.3390/polym15132928
31. Tao, Y., et al., Light: a magical tool for controlled drug delivery. Advanced Functional Materials, 2020. 30(49): p. 2005029.
https://doi.org/10.1002/adfm.202005029
32. Ehsanimehr, S., et al., Synthesis of pH-sensitive nanocarriers based on polyacrylamide grafted nanocrystalline cellulose for targeted drug delivery to folate receptor in breast cancer cells. European Polymer Journal, 2021. 150: p. 110398.
https://doi.org/10.1016/j.eurpolymj.2021.110398
33. Scattolin, T., et al., Synergistic applications of cyclodextrin-based systems and metal-organic frameworks in transdermal drug delivery for skin cancer therapy. Journal of Materials Chemistry B, 2024. 12(16): p. 3807-3839.
https://doi.org/10.1039/d4tb00312h
34. Gadade, D.D. and S.S. Pekamwar, Cyclodextrin based nanoparticles for drug delivery and theranostics. Advanced pharmaceutical bulletin, 2020. 10(2): p. 166.
https://doi.org/10.34172/apb.2020.022
35. Bergal, A., M. Andac, and F. Trotta, Cyclodextrin-based chemically modified pH-Responsive new kind of aldehyde-functionalized nanosponge nanoparticles for doxorubicin hydrochloride delivery. Journal of Drug Delivery Science and Technology, 2025. 107: p. 106853.
https://doi.org/10.1016/j.jddst.2025.106853
36. Peimanfard, S., et al., Developing novel hydroxypropyl-?-cyclodextrin-based nanosponges as carriers for anticancer hydrophobic agents: overcoming limitations of host-guest complexes in a comparative evaluation. Pharmaceutics, 2022. 14(5): p. 1059.
https://doi.org/10.3390/pharmaceutics14051059
37. Solanki, R. and S. Patel, Evodiamine and its nano?based approaches for enhanced cancer therapy: recent advances and challenges. Journal of the Science of Food and Agriculture, 2024. 104(14): p. 8430-8444.
https://doi.org/10.1002/jsfa.13612
38. Sandhya, S., et al. Multiple stimuli responsive cyclodextrin based smart materials for drug delivery: a review. in E3S Web of Conferences. 2021. EDP Sciences.
https://doi.org/10.1051/e3sconf/202130901014
39. Dheer, D., et al., Polysaccharides based nanomaterials for targeted anti-cancer drug delivery. Journal of drug targeting, 2017. 25(1): p. 1-16.
https://doi.org/10.3109/1061186x.2016.1172589
40. Mikušová, V. and P. Mikuš, Advances in chitosan-based nanoparticles for drug delivery. International journal of molecular sciences, 2021. 22(17): p. 9652.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
